000 01007 a2200277 4500
005 20250513164215.0
264 0 _c19990429
008 199904s 0 0 eng d
022 _a0277-6715
024 7 _a10.1002/(sici)1097-0258(19990115)18:1<107::aid-sim965>3.0.co;2-p
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFlandre, P
245 0 0 _aEstimating the proportion of treatment effect explained by a surrogate marker.
_h[electronic resource]
260 _bStatistics in medicine
_cJan 1999
300 _a107-9 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aBiomarkers
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aTreatment Outcome
650 0 4 _aZidovudine
_xpharmacology
700 1 _aSaidi, Y
773 0 _tStatistics in medicine
_gvol. 18
_gno. 1
_gp. 107-9
856 4 0 _uhttps://doi.org/10.1002/(sici)1097-0258(19990115)18:1<107::aid-sim965>3.0.co;2-p
_zAvailable from publisher's website
999 _c9952093
_d9952093